Perspectives for immunotherapy: which applications might achieve an HIV functional cure?

Archive ouverte

Vieillard, Vincent | Gharakhanian, Shahin | Lucar, Olivier | Katlama, Christine | Launay, Odile | Autran, Brigitte | Tsong Fang, Raphael Ho | Crouzet, Joël | Murphy, Robert L | Debré, Patrice

Edité par CCSD ; Impact journals -

International audience. The major advances achieved in devising successful combined antiretroviral therapy (cART) have enabled the sustained control of HIV replication. However, this is associated with costly lifelong treatment, partial immune restoration, chronic inflammation and persistent viral reservoirs. In this context, new therapeutic strategies deserve investigation as adjuncts to cART so as to potentiate immune responses that are capable of completely containing HIV pathogenicity, particularly if cART is discontinued. This may seem a dauntingly high hurdle given the results to date. This review outlines the key research efforts that have recently resurrected immunotherapeutic options, and some of the approaches tested to date. These areas include promising cytokines or vaccine strategies, using different viral or non-viral vectors based on polyvalent " mosaic " antigens and highly conserved HIV envelope peptides, broadly neutralizing antibodies or new properties of antibodies to improve the control of immune system homeostasis. These novel immunotherapeutic strategies appear promising per se, or in combination with TLR-agonists in order to bypass the complexity of the interplay between immune activation, massive CD4 + T-cell loss and viral persistence.

Suggestions

Du même auteur

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial

Archive ouverte | Vieillard, Vincent | CCSD

International audience. VAC-3S is a therapeutic vaccine comprising a highly conserved HIV-gp41 motif coupled with the CRM197 carrier protein. High levels of anti-3S antibodies (Abs) have been associated with improve...

Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status

Archive ouverte | Lucar, Olivier | CCSD

International audience. Antibodies (Abs) play a central role in human immunodeficiency virus (HIV) protection due to their multiple functional inhibitory activities. W614A-3S Abs recognize a specific form of a highl...

Accumulation of Intrahepatic TNF-a-Producing NKp44 NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV Infection

Archive ouverte | Nel, Isabelle | CCSD

International audience. In the setting of chronic hepatitis C virus (HCV) infection, changes in natural killer (NK) cells have been shown to reflect activation in response to virus stimulation. The contribution of i...

Chargement des enrichissements...